Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (942)	12/13/2001 11:03:42 AM
From: Crossy	Read Replies (1) \| Respond to of 1784

Tuck, as I see it FSH certainly fits your definition. Their 10K should tell. If you are unsure call the company. I think normally they would tell such a ratio. PKI did a bigger life science acquisition. I owned it once because of their photodiode business. It was a stellar investment for me (3 bagger). Opto with life science coverage is a very good hedge (for me life science of 30% would be "best" - unlike you) On Dalsa around 20% of their revenues are life science based. Oxford Instrument's 30-40% are definitely a better fit for your strategy.. rgrds CROSSY